JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BROOM, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BROOM, W. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 57, Issue 1, 81-97, 1936
Copyright © 1936 by American Society for Pharmacology and Experimental Therapeutics


THE TOXICITY AND GLYCAEMIC PROPERTIES OF A NUMBER OF AMIDINE AND GUANIDINE DERIVATIVES

W. A. BROOM 1

1 From the Department of Pharmacology, University of Sheffield

1. Twenty-three amidine and two guanidine compounds belonging to five different classes have been examined for toxicity to mice and rabbits and their effect on carbohydrate metabolism has been studied.

2. Certain of these compounds after a preliminary period of hyperglycaemia produced marked hypoglycaemia, whilst others produced hyperglycaemia only.

3. The two most active hypoglycaemic compounds were sebacamidine and n-decane-1:10 diamindine. Neither of these compounds was as active as synthalin and neither produced hypoglycaemia in any but lethal doses.

4. It is shown in a homologous series of diamidines that the toxicity and hypoglycaemic properties increase with the number of methylene groups uniting the amidine residues and that maximum activity occurs where either 8 or 10 such groups are present.

5. Where hypoglycaemia did occur it was not insulin-like in character, and was probably due to liver damage. It is suggested that the immediate effect of the hepatic injury is to deplete the liver of its stores of glycogen and to increase the blood sugar. Later, normal glyconeogenesis is prevented resulting in hypoglycaemia.

6. The extent of the liver and kidney damage was followed by amino acid and blood urea determinations and by histological examination.

7. It is suggested that amidine hyperglycaemia may, in part, be due to sympathetic stimulation.

8. Various inferences are drawn on the relationship of chemical structure to hypoglycaemic and toxic action.

9. None of the compounds examined possess any value as hypoglycaemic drugs for use in clinical medicine.

Submitted on February 18, 1936







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1936 by the American Society for Pharmacology and Experimental Therapeutics.